Rosh Chandraratna active positions
Companies | Position | Start | End |
---|---|---|---|
Io Therapeutics, Inc.
Io Therapeutics, Inc. BiotechnologyHealth Technology Io Therapeutics, Inc. develops retinoid and rexinoid molecule drugs for the treatment of cancer. The company is based in Spring, TX. The company was founded by Martin E. Sanders, Rosh Chandraratna. Martin E. Sanders has been the CEO since incorporation. | Director/Board Member | - | - |
Chief Tech/Sci/R&D Officer | - | - | |
Founder | - | - | |
President | - | - |
Career history of Rosh Chandraratna
Former positions of Rosh Chandraratna
Companies | Position | Start | End |
---|---|---|---|
NURX PHARMACEUTICALS INC | Director/Board Member | 30/04/2007 | 02/10/2009 |
Chief Tech/Sci/R&D Officer | 30/04/2007 | 02/10/2009 | |
ACUCELA INC | Chief Tech/Sci/R&D Officer | 31/08/2006 | 30/04/2007 |
VITAE PHARMACEUTICALS INC | Chief Tech/Sci/R&D Officer | 30/04/2004 | 31/08/2006 |
ALLERGAN, INC. | Chief Tech/Sci/R&D Officer | 30/04/2004 | 30/04/2004 |
Statistics
International
United States | 6 |
Operational
Chief Tech/Sci/R&D Officer | 5 |
Director/Board Member | 2 |
Founder | 1 |
Sectoral
Health Technology | 6 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 5 |
---|---|
Acucela, Inc.
Acucela, Inc. Pharmaceuticals: MajorHealth Technology Acucela, Inc. operates as a clinical-stage biotechnology company. It discovers and develops novel therapeutics to treat and show the progression of sight-threatening ophthalmic diseases. Its pipeline includes drug candidates and therapeutics for the treatment of age related macular degeneration, cataracts, presbyopia, diabetic retinopathy, retinitis igmentosa and Stargardt disease. The company was founded by Ryo Kubota in April 2002 and is headquartered in Seattle, WA. | Health Technology |
Vitae Pharmaceuticals LLC
Vitae Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vitae Pharmaceuticals LLC is a clinical-stage bio-pharmaceutical company, which engages in discovering and developing novel, small molecule drugs for diseases, including chronic kidney disease, diabetes and Alzheimer's disease, and autoimmune disorders, acute coronary syndrome, and immuno-oncology. The company was founded by John J. Baldwin, Bartosz A. Grzybowski, George M. Whitesides, and Eugene Shakhnovich on May 21, 2001 and is headquartered in Fort Washington, PA. | Health Technology |
NuRx Pharmaceuticals, Inc.
NuRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NuRx Pharmaceuticals, Inc. manufactures pharmaceutical products. It engages in treatment of cancer, chemotherapy associated neutropenia, bone marrow function, bone metabolism and lipid metabolism. The company was founded on August 14, 2001 and is headquartered in Irvine, CA. | Health Technology |
Allergan, Inc.
Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
Io Therapeutics, Inc.
Io Therapeutics, Inc. BiotechnologyHealth Technology Io Therapeutics, Inc. develops retinoid and rexinoid molecule drugs for the treatment of cancer. The company is based in Spring, TX. The company was founded by Martin E. Sanders, Rosh Chandraratna. Martin E. Sanders has been the CEO since incorporation. | Health Technology |
- Stock Market
- Insiders
- Rosh Chandraratna
- Experience